FDA approves generic valsartan amid drug shortage
(Reuters) – The U.S. Food and Drug Administration said on Tuesday it had approved a new generic version of blood pressure medicine valsartan, as the agency looks to ease shortages…
FDA approves Pfizer’s biosimilar to Roche’s Herceptin
FILE PHOTO: The logo of U.S. pharmaceutical corporation Pfizer Inc. is seen at a branch in Zurich, Switzerland October 2, 2018. REUTERS/Arnd Wiegmann (Reuters) – The U.S. Food and Drug…
Long-term obesity tied to higher dementia risk in healthy older adults
(Reuters Health) – Healthy older adults who have been obese for years may be at higher risk of developing dementia than their peers who aren’t overweight, research from the UK…
J&J nasal spray gets U.S. approval as first new type of anti-depressant in decades
(Reuters) – The U.S. Food and Drug Administration on Tuesday said it approved a Johnson & Johnson nasal spray antidepressant for people resistant to other treatments but placed restrictions on…
Allergan’s add-on treatment for depression fails late-stage studies
FILE PHOTO: The Allergan logo is seen in this photo illustration November 23, 2015. To match special report USA-FDA/CASES REUTERS/Thomas White/Illustration/File Photo (Reuters) – Allergan Plc said on Wednesday its…
FDA chief tough on e-cigs steps down in surprise resignation
WASHINGTON (Reuters) – U.S. Food and Drug Administration Commissioner Scott Gottlieb said on Tuesday that he plans to step down next month, a sudden resignation that calls into question how…
Exclusive: OxyContin maker Purdue Pharma exploring bankruptcy – sources
(Reuters) – OxyContin maker Purdue Pharma LP is exploring filing for bankruptcy to address potentially significant liabilities from roughly 2,000 lawsuits alleging the drugmaker contributed to the deadly opioid crisis…
Eli Lilly seeks to quell drug price anger with cheaper insulin
(Reuters) – Drugmaker Eli Lilly announced plans on Monday to sell a half-price version of its popular insulin injection Humalog, as it fends off criticism about rising drug prices in…
New cancer-causing toxin found in recalled blood pressure pills
(Reuters) – U.S. health regulators said on Friday a third cancer-causing toxin was found in some blood pressure pills recalled by India’s Hetero Labs Ltd a day earlier, adding to…
U.S. Senator Sanders urges FDA to allow older versions of $375,000 drug
(Reuters) – U.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and manufacturers to resume distributing unbranded, lower-cost versions of a drug used to treat a rare neuromuscular…